<?xml version="1.0" encoding="UTF-8" standalone="no"?>
<pubmed-document>
<record>
<header>
<identifier>17725170</identifier>
<setSpec>0303-8874</setSpec>
</header>
<metadata xmlns="http://example.org/myapp/" xmlns:dc="http://purl.org/dc/elements/1.1/" xmlns:dcterms="http://purl.org/dc/terms/" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xsi:schemaLocation="http://example.org/myapp/schema.xsd">
<dc:author>Lozano Ramírez, A</dc:author>
<dc:author>Labella Caballero, T</dc:author>
<dc:author>Rossi Izquierdo, M</dc:author>
<dc:author>Dios Loureiro, C</dc:author>
<dc:author>Cabanas Rodríguez, E</dc:author>
<dc:author>Frade González, C</dc:author>
<dc:description xml:lang="en">We analyse our results in the treatment of the tumors of the parotid gland, diagnosticated from 1981 till end of 2004. We saw 132 patients with tumors of the parotid, being 41 of them malignant. The surgical technique more used was the total parotidectomy with conservation of the facial nerve. The global survival obtained in the malignant tumors was 60% after five years. Surgery is the treatment of election in the tumors of epitelial origin of the parotid gland. The derived of the lymphoid tissue must be treated by other ways and are inheritance of the hematologic oncology.</dc:description>
<dc:type>Comparative Study</dc:type>
<dc:language>es</dc:language>
<dc:date>2007 </dc:date>
<dc:title xml:lang="es">Nuestra experiencia en el tratamiento de los tumores de glándula parótida.</dc:title>
<dc:title xml:lang="en">[Our experience in the treatment of the tumors of parotid gland].</dc:title>
<dc:publisher>Anales otorrinolaringologicos ibero-americanos</dc:publisher>
</metadata>
</record>
</pubmed-document>
